Bhagiradha Chemicals & Industries Limited has informed the Exchange regarding 'Investors Presentation on the Financial Highlights for the quarter ended December 31, 2025'.
BHAGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bhagiradha Chemicals reported Q3FY26 revenue of Rs. 114.0 crores, up 11% YoY, driven by better product mix and improved price realisations despite a marginal decline in volumes due to seasonal softness. EBITDA surged 49% YoY to Rs. 13.7 crores with margins expanding to 12.0% (from 8.9%), while PAT grew 28% YoY to Rs. 4.6 crores. Gross margins expanded sharply by 311 bps YoY to 43.0%, aided by process upgrades and a favourable product mix. For 9MFY26, revenue rose 19% to Rs. 377.8 crores and EBITDA grew 22% to Rs. 37.7 crores, though PAT dipped 4% to Rs. 14.1 crores due to elevated finance costs and depreciation. Management reiterated confidence in a strong ramp-up from the Bheema subsidiary facility and guided for better growth in FY27.
Positive near-term sentiment as Q3FY26 showed strong margin expansion and earnings growth despite seasonal volume softness. The long-term ~5x revenue target over 6-7 years, backed by the Rs. 800+ crore Bheema expansion, signals meaningful future growth, though near-term PAT remains pressured by higher interest and depreciation costs from the ongoing capex.